Bilenker Joshua H.
SEC-identified person · CIK 1612312 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Sana Biotechnology, Inc. SANA | Director | filed 2021 - 2026 |
| Gossamer Bio, Inc. GOSS | Director | filed 2019 - 2022 |
| Loxo Oncology, Inc. LOXO | Director · President & CEO | filed 2014 - 2019 |
| Viewray, Inc. VRAY | Director | filed 2016 - 2016 |
| T2 Biosystems, Inc. TTOO | Director | filed 2014 - 2016 |
| Roka Bioscience, Inc. ROKA | Director | filed 2014 - 2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.